Park Ave Peptides — Clinical Reference Library — For Professional Use Only

Cosmetic & Regenerative Research
cGMP facility · Third-party tested · Cold-chain shipping · 24-hour COA on request
Reference Compound
Educational reference for GLOW70. Scroll down for molecular profile, pharmacokinetics, mechanism, applications, and handling.
At a Glance
ShowQuality Documentation
Lot PAP-GLOW70-240118-A01 — Reference
Field of Medicine — Cosmetic & Regenerative Research
Endocrinology Research — GH-Axis Blend.
GLOW70 is a higher-content (70 mg) version of the GLOW research blend, combining a GHRH analog with selective ghrelin-receptor agonists in proportions formulated for extended-duration preclinical research.
Dual activation of GHRH and GHSR-1a receptors produces additive endogenous GH release with a pulsatile profile that more closely resembles physiologic patterns than continuous GH administration.
Reference Compound
GLOW70
02 — Science
03 — Pathway
Mechanism summaries for GLOW70 are drawn from peer-reviewed literature describing receptor binding, signaling pathways, and observed activity in preclinical models.
04 — Lab Reference
For licensed research and clinical evaluation only. Not dosing guidance.
Reconstitution
Bacteriostatic water (0.9% benzyl alcohol) or sterile water. Add diluent slowly along the vial wall — do not inject directly onto the lyophilized cake. Swirl gently until fully dissolved.
Storage
Lyophilized: −20°C long term; 2–8°C short term (weeks). Protect from light.Reconstituted: 2–8°C, generally up to 14–28 days depending on compound.
Quality
≥99% purity by HPLC. Identity confirmed by mass spectrometry. Independent third-party verification on every lot. COA available per lot.
Handling notes —Avoid repeated freeze–thaw cycles. Do not shake vigorously after reconstitution.
Need a full protocol brief?
Reconstitution worksheets, concentration reference cards, and sample COA for verified accounts.
05 — Common Questions
GLOW70 is presented here as a reference compound for clinicians and researchers. Regulatory status varies by jurisdiction and indication — see the official drug databases (FDA, EMA) for current approval information.
Yes. A lot-specific COA documenting identity and purity by HPLC and mass spectrometry is available on request through the Request Information form.
Each lot is analyzed by reverse-phase HPLC for purity and confirmed by mass spectrometry for identity. Independent third-party laboratory verification is performed on every lot.
Store the lyophilized vial refrigerated for short-term use, or frozen at −20°C for long-term storage. Once reconstituted, refrigerate and protect from light.
06 — Citations
The following sources are representative of the literature describing GLOW70. A full annotated citation list with PubMed identifiers is available on request.
See also the glossary of research terms and the full peptide library.
Comparative Reference
See molecular profile, pharmacokinetics, and handling next to related compounds in the same family.
Often Researched Alongside
cGMP facility · Third-party tested · Cold-chain shipping · 24-hour COA on request